Fully Invested

Tallawong, NSW

DA Approved Residential development site

The Loan is secured by a first registered mortgage over a DA approved residential development site, which forms Stage 1B of a multi-stage high density residential development.

The Security Property is situated within the suburb of Tallawong, approximately 45km west of the Sydney CBD. The area is currently characterised by low density residential developments, and has a high level of residential land subdivision and apartment projects in the planning stage of their development.

The purpose of the Loan was to provide equity from the unencumbered Security Property, to assist with early works at the site.

The Borrower has development approval in place for the construction of a five (5) storey residential building comprising 137 residential apartments, with one (1) used for ‘community purposes’ and 168 car spaces over a two (2) level basement area.

They Borrower is a Special Purpose Vehicle established for the development of the Security Property. The Borrower Group are highly experienced property developers based in Sydney and are currently engaged in an array of projects across Sydney. 

  • The Loan was advanced at a Loan to Value Ratio of 50%.
  • The Target Return is 6.70% p.a., net of fees and expenses, and is paid to Investors monthly in arrears.
  • The Loan is supported by multiple joint and several guarantees and a General Security Agreement over the Borrower and a related party entity.
  • Interest for the Term of the Loan has been lodged on deposit.
  • The Loan Term is 6 months, subject to early or late repayment, from 26 April 2021 to 25 October 2021.

Investment Details

  • Target Return
    6.7% net
  • Loan to Value Ratio
    50%
  • Term
    5 Months

Full details, unique to each investment, are provided to Investors in a Supplementary PDS. These detailed Supplementary PDS’s are only available to Investors in Balmain Private.

Start now by investing in an individual loan to commence building your own first mortgage investment portfolio with Balmain Private.